Gates Ventures

Lumotive LLC specializes in developing advanced solid-state lidar systems utilizing liquid crystal metasurface (LCM) technology, primarily aimed at enhancing sensing and perception capabilities in autonomous vehicles and various other industries. Founded in 2017 and based in Bellevue, Washington, the company produces optical semiconductor solutions, including its proprietary Light Control Metasurface beam steering chips. These chips are designed for seamless integration into consumer electronics, robotics, and industrial automation, offering a compact and efficient means of delivering precise light control. Lumotive's innovative technology aims to simplify lidar systems by reducing their complexity, cost, and size while simultaneously improving performance and reliability, thereby facilitating mass adoption across multiple applications.

Lumotive LLC specializes in developing advanced solid-state lidar systems utilizing liquid crystal metasurface (LCM) technology, primarily aimed at enhancing sensing and perception capabilities in autonomous vehicles and various other industries. Founded in 2017 and based in Bellevue, Washington, the company produces optical semiconductor solutions, including its proprietary Light Control Metasurface beam steering chips. These chips are designed for seamless integration into consumer electronics, robotics, and industrial automation, offering a compact and efficient means of delivering precise light control. Lumotive's innovative technology aims to simplify lidar systems by reducing their complexity, cost, and size while simultaneously improving performance and reliability, thereby facilitating mass adoption across multiple applications.

Vicarious Surgical Inc. is a robotics company based in Charlestown, Massachusetts, established in 2014. The company specializes in developing advanced technologies for minimally invasive surgical procedures, focusing on enhancing surgical efficiency, improving patient outcomes, and reducing healthcare costs. Its flagship product, the Vicarious Surgical Robotic System, integrates virtual reality software with human-like robotic capabilities, enabling surgeons to perform complex surgeries with greater precision and control. Designed for abdominal access through a single port, the system is compact and portable, facilitating easy integration into existing operating rooms. By minimizing invasiveness, Vicarious Surgical aims to accelerate patient recovery times and decrease post-operative discomfort, thereby transforming the landscape of surgical care.

Exicure, Inc. is a clinical-stage biotechnology company based in Chicago, Illinois, focused on developing therapeutics utilizing its proprietary spherical nucleic acid (SNA) technology. The company aims to address a range of conditions, including neurological disorders, immuno-oncology, inflammatory diseases, and genetic disorders. Its lead drug candidate, AST-008, is currently undergoing Phase 1b/2 clinical trials for advanced solid tumors. Additionally, Exicure is advancing XCUR-FXN, an SNA-based therapeutic for Friedreich’s ataxia in preclinical trials, and XCUR17, which targets the mRNA encoding interleukin 17 receptor alpha. The company has established collaborations with Allergan Pharmaceuticals to develop SNA-based treatments for hair loss and with DERMELIX, LLC for research and commercialization efforts related to netherton syndrome. Founded in 2011, Exicure is developing a new class of immunomodulatory and gene silencing drugs that enhance the delivery and efficacy of nucleic acid therapeutics.

Mainspring designs and develops digital business strategies. The company provides consulting services focusing on digital technologies, business optimization, and technology enablement. Mainspring, formerly known as Mainspring Communications Inc., was founded in 1996 and is based in Cambridge, Massachusetts.